{"result": {"id": "feb5dc67-32b8-46e5-a0bc-73c92d561c3d", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>肾动脉超声<|>ORGANIZATION<|>Renal artery ultrasound is the preferred imaging screening method for diagnosing renal artery stenosis>  \n##  \n(\"entity\"<|>磁共振血管造影<|>ORGANIZATION<|>Magnetic resonance angiography is an important confirmatory diagnostic tool for renal artery stenosis>  \n##  \n(\"entity\"<|>经皮选择性肾动脉造影<|>ORGANIZATION<|>Percutaneous selective renal arteriography is the gold standard for diagnosing renal artery stenosis>  \n##  \n(\"entity\"<|>β受体阻滞剂<|>ORGANIZATION<|>Beta-blockers are one of the multiple antihypertensive drugs used for renal vascular hypertension>  \n##  \n(\"entity\"<|>CCB<|>ORGANIZATION<|>Calcium channel blockers are part of the combined drug therapy for renal vascular hypertension>  \n##  \n(\"entity\"<|>利尿剂<|>ORGANIZATION<|>Diuretics are included in the multi-drug regimen for treating renal vascular hypertension>  \n##  \n(\"entity\"<|>α受体阻滞剂<|>ORGANIZATION<|>Alpha-blockers are used in combination therapy for renal vascular hypertension>  \n##  \n(\"entity\"<|>他汀类药物<|>ORGANIZATION<|>Statins are emphasized for atherosclerosis patients with renal artery stenosis>  \n##  \n(\"entity\"<|>肾动脉球囊扩张术<|>ORGANIZATION<|>Renal artery balloon angioplasty is the preferred method for non-atherosclerotic renal artery stenosis>  \n##  \n(\"relationship\"<|>肾动脉超声<|>磁共振血管造影<|>Both are diagnostic imaging methods for renal artery stenosis, with ultrasound being the initial screening tool and MRA being confirmatory<|>7>  \n##  \n(\"relationship\"<|>磁共振血管造影<|>经皮选择性肾动脉造影<|>MRA is a non-invasive diagnostic method while percutaneous arteriography is the invasive gold standard<|>6>  \n##  \n(\"relationship\"<|>β受体阻滞剂<|>CCB<|>Both are antihypertensive medications used in combination therapy for renal vascular hypertension<|>5>  \n##  \n(\"relationship\"<|>利尿剂<|>α受体阻滞剂<|>Both are part of the multi-drug treatment approach for renal vascular hypertension<|>5>  \n##  \n(\"relationship\"<|>他汀类药物<|>肾动脉球囊扩张术<|>Statins are used for atherosclerotic patients while balloon angioplasty is preferred for non-atherosclerotic cases<|>4>  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558780, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 576, "prompt_tokens": 2680, "total_tokens": 3256, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2624}, "prompt_cache_hit_tokens": 2624, "prompt_cache_miss_tokens": 56}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 性高血压 ;恶性高血压 ; 高血压伴低血钾 。②不 明原因的肾功能衰竭 ; 服用 ACEI/ARB治疗后肾功能恶化 ;一侧肾脏萎缩或两侧 肾脏长径相差 1.5 cm 以上 。③不明原因的心力衰竭 或一过性肺水肿 ;既往高血压可控制 ,降压药未变情况 下突然血压难以控制。\n　　诊断肾动脉狭窄的方法 : 肾动脉超声是首选的影 像学筛查手段 ; 肾动脉 CTA/磁共振血管造影是很重 要的确诊手段 ;经皮选择性肾动脉造影是诊断肾动脉 狭窄的“金标准”。\n　　　肾血管性高血压的诊断性评估 : 明确病因 ,病变部 位及程度 ,病理生理学诊断 ,血运重建是否获益。\n　10.2.1.2  治疗   所有的肾动脉狭窄患者都需要给予  优化的药物治疗 ,包括降压药物治疗和抗血小板治疗。 对于动脉粥样硬化患者 , 同时需要强调强化他汀类药  物的应用。\n　　ACEI/ARB可以作为肾血管性高血压患者的基 础用药 ;需要注意的是对于双侧肾动脉狭窄或孤立肾 的肾动脉狭窄 ,禁用 AECI和 ARB。大多数肾血管性 高血压患者通常需联合服用多种降压药 ,包括 β受体 阻滞剂、CCB、利尿剂和 α受体阻滞剂。\n　　　对 于 非 动 脉 粥 样 硬 化 肾 动 脉 狭 窄 患 者 , 包 括 FMD、大动脉炎等 ,推荐肾动脉血运重建治疗 , 肾动脉 球囊扩张术是首选方法 。对于动脉粥样硬化性肾动脉 狭窄患者 ,首选药物治疗[144,580] 。但对于以下几种情 况 ,建议肾动脉血运重建治疗[682]  : ①肾动脉狭窄合并 有一过性肺水肿、心力衰竭、心绞痛、急性冠脉综合征 的患者 ;②经过合理的药物治疗后 ,血压仍难以控制 , 肾功能仍有进行性恶化的患者 ; ③难治性高血压合并 有双肾动脉或者孤立肾动脉狭窄的患者 ; ④肾动脉狭 窄的跨病变收缩压压 差≥20 mmHg或者平均压压\n\n\n\n差≥10mmHg的患者。\n　10.2.2  主动脉狭窄   主动脉狭窄包括先天性及获得 性 。先天性称为主动脉缩窄 ,发病部位常在主动脉峡 部原动脉导管开口处附近 ,表现为主动脉的局限性狭 窄或闭锁 。获得性主动脉狭窄主要包括大动脉炎、动 脉粥样硬化及主动脉夹层等所致 。本病的基本病理生 理改变为狭窄所致血\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>ACEI/ARB<|>ORGANIZATION<|>ACEI/ARB are classes of drugs used in the treatment of hypertension and renal artery stenosis, with specific contraindications for certain conditions like bilateral renal artery stenosis or solitary kidney artery stenosis>  \n##  \n(\"entity\"<|>FMD<|>ORGANIZATION<|>FMD (Fibromuscular Dysplasia) is a non-atherosclerotic condition that can cause renal artery stenosis and is treated with renal artery revascularization>  \n##  \n(\"entity\"<|>CTA<|>ORGANIZATION<|>CTA (Computed Tomography Angiography) is an important diagnostic tool for confirming renal artery stenosis>  \n##  \n(\"relationship\"<|>ACEI/ARB<|>FMD<|>ACEI/ARB are used as baseline medications for renal vascular hypertension, but are contraindicated in certain conditions like FMD-related bilateral renal artery stenosis<|>6>  \n##  \n(\"relationship\"<|>CTA<|>FMD<|>CTA is used as a diagnostic tool to confirm renal artery stenosis, which can be caused by conditions like FMD<|>5>  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_92ca2f4167c0c5e5d0b055e88b4b9bb36d5123bd84eecbbc647df7703387fa82_v2"}